Talniflumate abrogates mucin immune suppressive barrier improving efficacy of gemcitabine and nab-paclitaxel treatment in pancreatic cancer.
Agostini A, Guerriero I, Piro G, Quero G, Roberto L, Esposito A, Caggiano A, Priori L, Scaglione G, De Sanctis F, Sistigu A, Musella M, Larghi A, Rizzatti G, Lucchetti D, Alfieri S, Sgambato A, Bria E, Bizzozero L, Arena S, Ugel S, Corbo V, Tortora G, Carbone C.
Agostini A, et al. Among authors: ugel s.
J Transl Med. 2023 Nov 23;21(1):843. doi: 10.1186/s12967-023-04733-z.
J Transl Med. 2023.
PMID: 37996891
Free PMC article.